Office Action Predictor
Last updated: April 15, 2026
Application No. 18/316,046

APPARATUS AND METHOD FOR BIOLOGICAL TISSUE PUNCTURE EXPANSION

Final Rejection §102§103§112
Filed
May 11, 2023
Examiner
LOUIS, RICHARD G
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boston Scientific Medical Device Limited
OA Round
2 (Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
3y 4m
To Grant
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allow Rate
699 granted / 939 resolved
+4.4% vs TC avg
Strong +25% interview lift
Without
With
+24.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
49 currently pending
Career history
988
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
24.1%
-15.9% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 939 resolved cases

Office Action

§102 §103 §112
/Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Detailed Action This is in response to the amendment filed 10/09/2025 Claim Objections Claims 5-7 are objected to because of the following informalities: Claims 5-7 refers to the distal buckling member, whereas the previous claims recite one or more distal buckling members. Appropriate correction is required. Allowable Subject Matter Claims 10, 12 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Claim 10 recites wherein the distal expansion portion is comprised of a pre-defined sloping geometry on the inner shaft and one or more split distal outer shaft segments on the outer sliding shaft. claim 12 recites indicators along the length of the elongated introducer assembly corresponding to the outer diameter of the distal expansion portion concomitant with the position of the outer sliding shaft relative to the inner shaft. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by U.S. Patent Publication Number 2007/0142778 (Elbert et al). Regarding claim 1, Elbert et al. discloses as shown in Figure 7, an apparatus capable of expanding patient tissue, the apparatus comprising: an elongated introducer assembly configured to be maneuvered toward and positioned proximate to a puncture hole of a tissue wall; the elongated introducer assembly including a distal end (bulbous portion of outer sheath 132 shown in Figure 7), an inner shaft (outer sheath 122, see paragraph [0037]) and an outer sliding shaft (outer sheath 132, see paragraph [0038]); the outer sliding shaft being concentrically situated and longitudinally movable relative to the inner shaft; and a distal expansion portion (wings 136, 137, see paragraph [0036]) contiguous with the outer sliding shaft; wherein selective linear movement of the outer sliding shaft relative to the inner shaft forces the distal expansion portion against the distal end and actuates radial expansion of the distal expansion portion. Claim(s) 1-5, 9, 11, 13, 14, 16, 19-21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by U.S. Patent Number 5,836,913 (Orth et al). Regarding claims 1-5, 9, 11, 13, 14, 16, 19-21 Orth et al. discloses as shown in Figures 2A-2C, an apparatus capable of expanding patient tissue and a method for use with a puncture hole in a tissue wall, the apparatus comprising: an elongated introducer assembly configured to be maneuvered toward and positioned proximate to a puncture hole of a tissue wall; the elongated introducer assembly including a distal end (obturator 11, abstract), an inner shaft (tubular member 12, see abstract) and an outer sliding shaft (non-expandable 18, see abstract); the outer sliding shaft being concentrically situated and longitudinally movable relative to the inner shaft; and a distal expansion portion (expandable region 19, see abstract) contiguous with the outer sliding shaft; wherein selective linear movement of the outer sliding shaft relative to the inner shaft forces the distal expansion portion against the distal end and actuates radial expansion of the distal expansion portion, wherein the distal expansion portion is comprised of one or more distal buckling members (strands of braid) that are lower in stiffness than the outer sliding shaft, wherein the distal expansion portion is comprised of an expansion member (one strand of the braid) and one or more distal buckling members (other strands of the braid), wherein the expansion member is a segment of the outer sliding shaft that is adjacent to the one or more distal buckling members, wherein the distal buckling member is lower in stiffness than the outer sliding shaft and the expansion member, wherein the distal buckling member is comprised of a polymer material, wherein the outer sliding shaft is selectively moved relative to the inner shaft via an outer sliding shaft advancer, wherein the inner shaft includes a hollow lumen, wherein the elongated introducer assembly includes a proximal hub. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 6-8 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Number 5,836,913 (Orth et al) in view of U.S. Patent Publication Number 2003/0023266 (Borillo et al.) Regarding claims 6, 7 Orth et al. fails to disclose wherein the distal buckling member is comprised of nitinol, wherein the distal buckling member is formed by laser-cutting or any other material-removal process.. Borillo et al. from a related field of endeavor teaches a similar buckling member, where the distal buckling member is comprised of nitinol, wherein the distal buckling member is formed by laser-cutting or any other material-removal process. See paragraph [0041]. It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention to modify the distal buckling member disclosed by Orth by substituting the material of the distal buckling member disclosed by Orth et al. for the material of the distal buckling member because it would only require the simple substitution of one known alternative for another to produce nothing but predictable results. See KSR International Co. v. Teleflex Inc., 550 U.S. 398, 82, USPQ2d 1385 (2007). Regarding claim 8, E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process." In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985) (citations omitted) In this case, the product in the product-by-process claim is the same as or obvious from a product of Orth et al. and the Office interprets Orth et al. as disclosing wherein the distal buckling member is formed by laser-cutting or any other material-removal process, wherein the distal buckling member is formed by flattening. Claim(s) 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Number 5,836,913 (Orth et al) in view of U.S. Patent Publication Number 2006/0063973 (Makower et al.) Regarding claim 15, Orth et al. discloses wherein the proximal hub has a luer connector (28, see paragraph [0025]). Orth et al. fails to disclose the luer connector is female. Makower et al., from the same filed of endeavor teaches a similar apparatus as shown in Figure 27A, 27B where the luer connector is female. See paragraph [0222]. It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention to modify the apparatus disclosed by Orth et al. by substituting the luer connector disclosed by Orth et al. for the luer connector taught Makower because it would only require the simple substitution of one known alternative for another to produce nothing but predictable results. See KSR International Co. v. Teleflex Inc., 550 U.S. 398, 82, USPQ2d 1385 (2007). Claim(s) 17 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Number 5,836,913 (Orth et al.) in view of U.S. Patent Publication Number 2011/0152760 (Parker al.) Regarding claim 17, Orth et al. fails to disclose positioning the distal tip proximate to the puncture hole in the tissue wall further includes forming the puncture wall by advancing a puncture device through a hollow lumen whereby the puncture device exits the elongated introducer assembly via the distal tip of the distal end forms the puncture hole in the wall. Parker al., from the same field of endeavor teaches a similar method as shown in Figures 6, 7 where the distal tip proximate to the puncture hole in the tissue wall further includes forming the puncture wall by advancing a puncture device (guidewire 80, see paragraph [0026]) through a hollow lumen whereby the puncture device exits the elongated introducer assembly via the distal tip of the distal end forms the puncture hole in the wall, for the purpose of guding the introducer assembly. It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention to modify the method dsicsloed by Orth et al. to include the steps of positioning the distal tip proximate to the puncture hole in the tissue wall further includes forming the puncture wall by advancing a puncture device through a hollow lumen whereby the puncture device exits the elongated introducer assembly via the distal tip of the distal end forms the puncture hole in the wall in order to guide the introducer assembly through the body. Response to Arguments Applicant’s arguments, see page 6, filed 10/09/2025, with respect to the rejections of claims 16-20 under 35 USC 112 have been fully considered and are persuasive. The rejections of claims 16-20 under 35 USC 112 have been withdrawn. The applicant’s remaining remarks have been considered moot in view of the new grounds of rejection. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RICHARD G LOUIS whose telephone number is (571)270-1965. The examiner can normally be reached on Monday – Friday, 9:30 am – 6 pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Jackie Ho at 571-272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. If there are any inquiries that are not being addressed by first contacting the Examiner or the Supervisor, you may send an email inquiry to TC3700_Workgroup_D_Inquiries@uspto.gov. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RICHARD G LOUIS/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

May 11, 2023
Application Filed
Jul 12, 2025
Non-Final Rejection — §102, §103, §112
Oct 09, 2025
Response Filed
Jan 27, 2026
Final Rejection — §102, §103, §112
Mar 30, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594077
An endoscopic magnetic anastomosis system, and methods and devices for forming an anastomosis
2y 5m to grant Granted Apr 07, 2026
Patent 12588928
MEDICAL DEVICE INSERTERS AND PROCESSES OF INSERTING AND USING MEDICAL DEVICES
2y 5m to grant Granted Mar 31, 2026
Patent 12588904
IMPLANT DEVICES AND FABRICATION METHODS FOR IMPLANT DEVICES
2y 5m to grant Granted Mar 31, 2026
Patent 12589198
CYCLIC ASPIRATION SYSTEM PRODUCING CYCLIC ASPIRATION PRESSURE WAVEFORM USING VACUUM PUMP AND POSITIVE PRESSURE PULSE GENERATOR MECHANISM
2y 5m to grant Granted Mar 31, 2026
Patent 12582424
ASPIRATION CATHETER SYSTEMS AND METHODS OF USE
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+24.6%)
3y 4m
Median Time to Grant
Moderate
PTA Risk
Based on 939 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month